Karo Healthcare AB ("Karo") has entered an exclusive licensing agreement with Moberg Pharma AB ("Moberg Pharma") regarding ...
For manufacturers, the tinea pedis treatment market offers a resilient, expanding, and innovation-driven ecosystem. With a projected CAGR of 5.2% through 2035, the sector presents sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback